ClinicalTrials.gov: First posted in the last 14 days

Conditions: Congestive Heart Failure; Emotions; Patient Compliance
Interventions: Behavioral: PP-based health behavior intervention; Behavioral: MI-based educational control condition
Sponsors: Massachusetts General Hospital; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified July 2017

Condition: Dental Implants
Interventions: Other: PICN (VITA Enamic) hybrid abutment crown; Other: Lithium disilicate (IPS e.max) hybrid abutment crown
Sponsor: Cairo University
Not yet recruiting - verified July 2017

Condition: Solid Tumor
Interventions: Radiation: Stereotactic radiotherapy; Other: Biological: humanized anti-PD-1 monoclonal antibody; Other: Biological: humanized anti-PD-L1 monoclonal antibody
Sponsors: Virginia Commonwealth University; National Cancer Institute (NCI)
Not yet recruiting - verified July 2017

Conditions: Fistula Vagina; Crohn Disease
Intervention: Drug: MSC-AFP
Sponsor: Mayo Clinic
Not yet recruiting - verified July 2017

Conditions: Alcohol Use Disorder; Bipolar Disorder
Interventions: Drug: N-Acetylcysteine; Drug: Gabapentin; Drug: Placebo Oral Tablet
Sponsors: Medical University of South Carolina; National Institutes of Health (NIH); National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified July 2017

Condition: Bone Resorption
Interventions: Procedure: Drilling at low speed; Procedure: Drilling at conventional or high speed
Sponsor: Cairo University
Active, not recruiting - verified July 2017

Condition: Bone Resorption
Interventions: Procedure: Drilling at low speed; Procedure: Conventional drilling at high speed
Sponsor: Cairo University
Active, not recruiting - verified July 2017

Condition: Amphetamine Addiction
Intervention: Behavioral: Music therapy group
Sponsor: Shanghai Mental Health Center
Not yet recruiting - verified July 2017

Condition: Breast Cancer
Interventions: Diagnostic Test: Molecular Breast Imaging; Diagnostic Test: Digital Breast Tomosynthesis
Sponsor: Mayo Clinic
Recruiting - verified July 2017

Conditions: Low Back Pain; Back Pain; Pain; Signs and Symptoms; Neuromuscular Manifestations
Interventions: Behavioral: Cognitive Functional Therapy; Other: Manual Therapy and Motor Control Exercise
Sponsors: Centro Universitário Augusto Motta; Rio de Janeiro State Research Supporting Foundation (FAPERJ)
Not yet recruiting - verified July 2017

Conditions: Smoking, Tobacco; Smoking Cessation
Interventions: Behavioral: Motivational Interviewing; Behavioral: Traditional cognitive-behavioral approach
Sponsors: Hospital Nossa Senhora da Conceicao; Federal University of Rio Grande do Sul
Recruiting - verified July 2017

Condition: Biting Force
Interventions: Device: thermoplastic complete denture; Device: conventional acrylic resin complete denture
Sponsor: Cairo University
Not yet recruiting - verified February 2017

Condition: Patient-Controlled Analgesia
Intervention: Device: Patient-Controlled Analgesia(PCA)
Sponsor: Weifeng Tu
Completed - verified July 2017

Conditions: Family Conflict; Suicidal Ideation
Interventions: Behavioral: Early Intervention for Suicide Risk Among Immigrant Youth; Behavioral: Enhanced usual care
Sponsor: Massachusetts General Hospital
Not yet recruiting - verified July 2017

Condition: Colorectal Neoplasms
Interventions: Procedure: Surgery and HIPEC with Lobaplatin; Procedure: Surgery without HIPEC
Sponsors: Sixth Affiliated Hospital, Sun Yat-sen University; Second Affiliated Hospital, Sun Yat-Sen University; Zhujiang Hospital; First Affiliated Hospital of Jinan University; The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine; Second Affiliated Hospital of Guangzhou Medical University; Guangzhou General Hospital of Guangzhou Military Command; Tcm-integrated Cancer Center of Southern Medical University; Affiliated Tumor Hospital of Guangzhou Medical University; Nanfang Hospital of Southern Medical University; Guangdong Provincial Hospital of Traditional Chinese Medicine
Not yet recruiting - verified July 2017

Condition: Multiple Myeloma
Interventions: Biological: Pembrolizumab; Biological: Daratumumab
Sponsor: Merck Sharp & Dohme Corp.
Not yet recruiting - verified July 2017

Conditions: Gastric Cancer; Gastroesophageal Junction Cancer
Interventions: Biological: Pembrolizumab; Drug: Placebo; Drug: Cisplatin; Drug: Capecitabine; Drug: 5-fluorouracil
Sponsor: Merck Sharp & Dohme Corp.
Not yet recruiting - verified July 2017

Conditions: Advanced Malignant Solid Neoplasm; BRAF NP_004324.2:p.V600X; Ependymoma; Ewing Sarcoma; Hepatoblastoma; Histiocytosis; Langerhans Cell Histiocytosis; Malignant Germ Cell Tumor; Malignant Glioma; Osteosarcoma; Peripheral Primitive Neuroectodermal Tumor; Recurrent Childhood Central Nervous System Neoplasm; Recurrent Childhood Non-Hodgkin Lymphoma; Recurrent Malignant Solid Neoplasm; Recurrent Neuroblastoma; Refractory Central Nervous System Neoplasm; Refractory Malignant Solid Neoplasm; Refractory Neuroblastoma; Refractory Non-Hodgkin Lymphoma; Rhabdoid Tumor; Rhabdomyosarcoma; Soft Tissue Sarcoma; Stage III Childhood Non-Hodgkin Lymphoma; Stage IV Childhood Non-Hodgkin Lymphoma; Wilms Tumor
Interventions: Other: Laboratory Biomarker Analysis; Drug: Vemurafenib
Sponsor: National Cancer Institute (NCI)
Not yet recruiting - verified July 2017

Conditions: AIDS-Related Lymphoma; CD20 Positive; HIV Positivity; Stage II Diffuse Large B-Cell Lymphoma; Stage III Diffuse Large B-Cell Lymphoma; Stage IV Diffuse Large B-Cell Lymphoma
Interventions: Drug: Cyclophosphamide; Drug: Doxorubicin Hydrochloride; Drug: Etoposide; Biological: Filgrastim; Drug: Ibrutinib; Other: Laboratory Biomarker Analysis; Biological: Pegfilgrastim; Other: Pharmacological Study; Drug: Prednisone; Biological: Rituximab; Drug: Vincristine Sulfate
Sponsor: National Cancer Institute (NCI)
Not yet recruiting - verified July 2017

Conditions: Cervical Carcinoma; Esophageal Carcinoma; Mucosal Melanoma; Mucosal Melanoma of the Head and Neck; Oral Cavity Mucosal Melanoma; Recurrent Melanoma; Stage II Vulvar Cancer; Stage III Vulvar Cancer; Stage IIIA Vulvar Cancer; Stage IIIB Vulvar Cancer; Stage IIIC Vulvar Cancer; Stage IV Oral Cavity Cancer AJCC v6 and v7; Stage IV Vulvar Cancer; Stage IVA Oral Cavity Cancer AJCC v6 and v7; Stage IVB Oral Cavity Cancer AJCC v6 and v7; Stage IVC Oral Cavity Cancer AJCC v6 and v7; Vaginal Carcinoma
Interventions: Procedure: Conventional Surgery; Biological: Ipilimumab; Other: Laboratory Biomarker Analysis; Biological: Nivolumab; Other: Patient Observation; Radiation: Radiation Therapy
Sponsor: National Cancer Institute (NCI)
Not yet recruiting - verified July 2017

Latest Images